As we enter February 2026, global markets are navigating a complex landscape marked by steady interest rates from the Federal Reserve and mixed performances across major indices, with small- and mid-cap stocks underperforming their larger counterparts. Amid these conditions, identifying promising small-cap opportunities often involves looking for companies that can thrive despite broader economic challenges and exhibit signs of potential growth through strategic insider activity.
Top 10 Undervalued Small Caps With Insider Buying Globally
| Name |
PE |
PS |
Discount to Fair Value |
Value Rating |
|---|---|---|---|---|
| Tokmanni Group Oyj |
12.9x |
0.3x |
42.89% |
★★★★★☆ |
| A.G. BARR |
15.6x |
1.8x |
49.98% |
★★★★☆☆ |
| Eurocell |
16.7x |
0.3x |
33.56% |
★★★★☆☆ |
| Hargreaves Services |
11.4x |
0.8x |
18.43% |
★★★★☆☆ |
| East West Banking |
3.4x |
0.8x |
15.41% |
★★★★☆☆ |
| M&C Saatchi |
23.2x |
0.4x |
47.01% |
★★★★☆☆ |
| Eastnine |
12.3x |
7.8x |
49.07% |
★★★★☆☆ |
| Young's Brewery |
45.3x |
1.0x |
32.64% |
★★★☆☆☆ |
| PSC |
9.8x |
0.4x |
19.52% |
★★★☆☆☆ |
| Linc |
NA |
NA |
6.44% |
★★★☆☆☆ |
Let's uncover some gems from our specialized screener.
NIOX Group
Simply Wall St Value Rating:★★★☆☆☆
Overview:NIOX Group focuses on developing and commercializing medical devices for asthma diagnosis and management, with a market cap of £0.23 billion.
Operations:The company's revenue primarily comes from its NIOX® segment, with a reported revenue of £46 million. The gross profit margin has shown an upward trend, reaching 71.09% in recent periods. Operating expenses have been consistently managed around £23-24 million, with significant allocations towards sales and marketing as well as research and development. Net income has improved over time, transitioning from negative figures to a positive net income margin of 10.65%.
PE:56.0x
NIOX Group, a small company with insider confidence shown through recent share purchases, is catching attention for its growth potential. While earnings are projected to rise by 35% annually, profit margins have decreased from 28.2% to 10.7%. The company's liabilities are entirely funded through external borrowing, adding risk but also highlighting potential for financial restructuring. With these dynamics in play, NIOX presents an intriguing opportunity for those eyeing smaller companies with growth prospects.
Ainsworth Game Technology
Simply Wall St Value Rating:★★★★☆☆
Overview:Ainsworth Game Technology is a company that specializes in the design, development, and manufacturing of gaming machines and related equipment and services, with a market cap of A$194.08 million.
Operations:AGI's primary revenue stream comes from gaming machines and related services, generating A$294.76 million. The gross profit margin shows a notable fluctuation, peaking at 64.43% before declining to 55.71%. Operating expenses are significant, with sales and marketing being the largest component at A$64.79 million, followed by R&D expenses of A$47.88 million in the latest period reviewed.
PE:16.6x
Ainsworth Game Technology, a player in the gaming equipment industry, has caught attention due to recent insider confidence. Over the past six months, insiders have increased their holdings, suggesting optimism about its prospects. Despite facing higher risk from external borrowing as its sole funding source and an anticipated 2.6% annual earnings decline over three years, Ainsworth's current market price may not fully reflect its potential value. The company's strategic moves and industry positioning could offer growth opportunities amidst these challenges.
Nufarm
Simply Wall St Value Rating:★★★★☆☆
Overview:Nufarm is an agricultural chemical company specializing in crop protection and seed technologies, with a market cap of A$2.42 billion.
Operations:Nufarm's revenue streams are primarily derived from its Crop Protection segments across APAC, Europe, and North America, along with its Seed Technologies Global segment. The company's gross profit margin has shown fluctuations over the periods observed, reaching a peak of 29.49% in September 2023 before declining to 26.28% by June 2024. Operating expenses have consistently been significant, with sales and marketing being a major component.
PE:-4.7x
Nufarm, a player in the agriculture chemicals sector, is navigating financial challenges with a reported net loss of A$165 million for the year ending September 2025. Despite this, earnings are projected to grow significantly by 90.81% annually. The company has seen insider confidence through share purchases over recent months, indicating belief in future potential. Leadership changes are underway with Rico Christensen stepping in as CEO from January 2026, bringing extensive global experience and strategic vision to drive operational excellence and growth initiatives.
-
Get an in-depth perspective on Nufarm's performance by reading our valuation report here.
-
Review our historical performance report to gain insights into Nufarm's's past performance.
Key Takeaways
-
Get an in-depth perspective on all 135 Undervalued Global Small Caps With Insider Buying by using our screener here.
-
Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St , where you can monitor all the vital signs of your stocks effortlessly.
-
Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Want To Explore Some Alternatives?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
-
Find companies with promising cash flow potential yet trading below their fair value .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIM:NIOX ASX:AGI and ASX:NUF.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
